anesthesia guidelines for glp-1 Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care glp 1 anesthesia guidelines GLP-1

Nonalcoholic steatohepatitis is the most common cause of chronic liver disease in the western countries (up to 24% of all patients with liver disease), with 75% of those with NASH being classified as obese (1)

This has practical implications for prescribers who now routinely field requests based on perceived celebrity endorsement

From venom to vital medicine, the journey of GLP-1s underscores why continued investment in research is essential

This biological infrastructure makes the gastrointestinal tract a natural target for peptide-based research and two compounds in particular have emerged with substantial published evidence: BPC-157 and KPV